Arkolith/Insider Trading/TXG/Form 4

Saxonov Serge

Chief Executive Officer, Director10x Genomics, Inc. (TXG) · full profile →Form 4 · filed Dec 18, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$110K
Net Open-Market Flow
-$110K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 14, 2023Sell(S)2K$55.15$94K845K
Dec 14, 2023Sell(S)300$54.39$16K847K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-23-000402) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML